NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

微生物群的全球市場機遇和策略(到 2030 年):嚴重急性呼吸系統症候群 (COVID-19) 的影響和增長

Microbiome Global Market Opportunities And Strategies To 2030: COVID-19 Implications and Growth

出版商 The Business Research Company 商品編碼 1014715
出版日期 內容資訊 英文 313 Pages
商品交期: 2-3個工作天內
價格
微生物群的全球市場機遇和策略(到 2030 年):嚴重急性呼吸系統症候群 (COVID-19) 的影響和增長 Microbiome Global Market Opportunities And Strategies To 2030: COVID-19 Implications and Growth
出版日期: 2021年06月16日內容資訊: 英文 313 Pages
簡介

本報告分析了全球微生物群市場,分析了市場的主要特徵和結構、整體市場規模和增長率前景,以及按行業、地區和主要國家劃分的詳細趨勢。我們正在調查與主要宏觀經濟的比較指標、大公司概況、近年重大併購(M&A)、未來增長機會。

目錄

第 1 章微生物組市場:執行摘要

第 2 章目錄

第 3 章圖列表

第 4 章表格列表

第 5 章分析結構

第 6 章介紹

第 7 章微生物組市場的特徵

  • 市場定義
  • 市場細分

第 8 章新型冠狀病毒傳染病 (COVID-19):對微生物組市場的影響

第 9 章微生物組市場趨勢和策略

  • 戰略合作與簽約
  • 管道研究和藥物開發數量增加
  • 增加對癌症微生物組治療開發的投資
  • 終端行業的趨勢
    • 增加農業領域的微生物組研究
    • 對益生菌的需求增加
    • 皮膚微生物組產品

第 10 章全球微生物組市場:市場規模和增長率

  • 市場規模
  • 市場規模:實際值(金額基準,2015-2020)
    • 市場促進因素(2015-2020)
    • 市場製約因素(2015-2020)
  • 市場規模:預測值(金額基準,2020-2025、2030)
    • 市場促進因素(2020-2025)
    • 市場製約因素(2020-2025)

第 11 章全球微生物組市場:詳細分析

  • 全球微生物群市場規模:按最終用途行業(金額基準,2015-2025/2025/2030)
    • 農業/環境
    • 其他
    • 食物/飼料
    • 人類診斷藥物
    • 人類療法
    • 全球人類微生物組治療藥物市場:按類型分類(金額基準,2023-2030 年)
    • 全球人類微生物組治療藥物市場:按應用(金額基準,2023-2030)
    • 傳染病
    • 癌症
    • 胃腸道疾病
    • 代謝紊亂

第 12 章微生物組市場:區域/國家分析

  • 按地區劃分的市場規模(金額基準,2015-2020/2020-2025/2030)
  • 按國家/地區劃分的市場規模(金額基準,2015-2020/2020-2025/2030)

第 13 章亞太微生物組市場

  • 市場概覽
  • 市場規模,實際價值(金額基準,2015-2020)
  • 市場規模,預測值(金額基準,2020-2025,2030)
  • 市場規模:按終端行業(金額基準,2015-2025/2025/2030)
    • 人類微生物組治療藥物市場:按類型(金額基準,2023-2030)
    • 人體微生物組治療藥物市場:按應用(金額基準,2023-2030)
  • 亞太微生物組市場:國家分析
  • 中國市場
  • 印度市場
  • 日本市場
  • 澳大利亞市場
  • 印尼市場
  • 韓國市場

第 14 章西歐微生物組市場

  • 市場概覽
  • 市場規模,實際價值(金額基準,2015-2020)
  • 市場規模,預測值(金額基準,2020-2025,2030)
  • 市場規模:按終端行業(金額基準,2015-2025/2025/2030)
    • 人類微生物組治療藥物市場:按類型(金額基準,2023-2030)
    • 人體微生物組治療藥物市場:按應用(金額基準,2023-2030)
  • 西歐微生物組市場:國家分析
  • 英國市場
  • 德國市場
  • 法國市場

第 15 章東歐微生物組市場

  • 市場概覽
  • 市場規模,實際價值(金額基準,2015-2020)
  • 市場規模,預測值(金額基準,2020-2025,2030)
  • 市場規模:按終端行業(金額基準,2015-2025/2025/2030)
    • 人類微生物組治療藥物市場:按類型(金額基準,2023-2030)
    • 人體微生物組治療藥物市場:按應用(金額基準,2023-2030)
  • 東歐微生物組市場:國家分析
  • 俄羅斯市場

第 16 章北美微生物組市場

  • 市場概覽
  • 市場規模,實際價值(金額基準,2015-2020)
  • 市場規模,預測值(金額基準,2020-2025,2030)
  • 市場規模:按終端行業(金額基準,2015-2025/2025/2030)
    • 人類微生物組治療藥物市場:按類型(金額基準,2023-2030)
    • 人體微生物組治療藥物市場:按應用(金額基準,2023-2030)
  • 北美微生物組市場:國家分析
  • 美國市場

第 17 章南美微生物組市場

  • 市場概覽
  • 市場規模,實際價值(金額基準,2015-2020)
  • 市場規模,預測值(金額基準,2020-2025,2030)
  • 市場規模:按終端行業(金額基準,2015-2025/2025/2030)
    • 人類微生物組治療藥物市場:按類型(金額基準,2023-2030)
    • 人體微生物組治療藥物市場:按應用(金額基準,2023-2030)
  • 南美微生物組市場:國家分析
  • 巴西市場

第 18 章中東微生物組市場

  • 市場概覽
  • 市場規模,實際價值(金額基準,2015-2020)
  • 市場規模,預測值(金額基準,2020-2025,2030)
  • 市場規模:按終端行業(金額基準,2015-2025/2025/2030)
    • 人類微生物組治療藥物市場:按類型(金額基準,2023-2030)
    • 人體微生物組治療藥物市場:按應用(金額基準,2023-2030)

第 19 章非洲微生物組市場

  • 市場概覽
  • 市場規模,實際價值(金額基準,2015-2020)
  • 市場規模,預測值(金額基準,2020-2025,2030)
  • 市場規模:按終端行業(金額基準,2015-2025/2025/2030)
    • 人類微生物組治療藥物市場:按類型(金額基準,2023-2030)
    • 人體微生物組治療藥物市場:按應用(金額基準,2023-2030)

第 20 章全球微生物組市場的競爭態勢

  • 公司簡介
  • Assembly Biosciences
    • 公司簡介
    • 產品/服務
    • 經營戰略
    • 主要財務指標
  • Enterome Bioscience
  • Ferring Pharmaceuticals
  • Vedanta BioSciences
  • Seres Therapeutics
  • Second Genome Inc.

第 21 章微生物組市場的重大併購(M&A)

第 22 章微生物組市場:市場機會和策略

  • 微生物組市場(2025 年):提供最新市場機會的國家
  • 微生物組市場(2025 年):提供最新市場機會的部門
  • 微生物組市場(2025 年):增長戰略
    • 基於市場趨勢的策略
    • 競爭對手戰略

第 23 章全球微生物組市場:結論和建議

第 24 章附錄

目錄
Product Code: o&s263

Micobiome Global Market Opportunities And Strategies To 2030: COVID-19 Implications and Growth from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global micobiome market as it emerges from the COVID -19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the micobiome? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The micobiome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider micobiome market, and compares it with other markets.

The report covers the following chapters

Executive Summary - The executive summary section of the report gives a brief overview and summary of the report

Report Structure - This section gives the structure of the report and the information covered in the various sections.

Introduction - The introduction section of the report gives brief introduction about segmentation by geography, and segmentation by automation type and by application.

Market Characteristics - The market characteristics section of the report defines and explains the micobiome market. This chapter includes different products covered in the report and basic definitions.

Trends And Strategies - This chapter describes the major trends shaping the global micobiome market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

COVID -19 Impact - This chapter describes the COVID -19 impact on the global micobiome market.

Global Market Size And Growth - This section contains the global historic (2015-2020) and forecast (2020-2025) and (2025-2030) market value, and drivers and restraints that support and control the growth of the market in the historic and forecast period.

Regional And Country Analysis - This section contains the historic (2015-2020), forecast (2020-2025) market value and growth and market share comparison by region and country.

Market Segmentation - This section contains the market values (2015-2020), (2020-2025), and (2025-2030) and analysis for different segments in the market.

Regional Market Size And Growth - This section contains the region's market size (2020), historic (2015-2020) and forecast (2020-2025) and (2025 - 2030) market values, and growth and market share comparison of major countries within the regions. (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).

Competitive Landscape - This section covers details on the competitive landscape of the global micobiome market, estimated market shares and company profiles of the leading players.

Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.

Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for micobiome companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups.

Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered: 1) By End Use Industry: Human Therapeutics; Human Diagnostics; Agriculture & Environmental; Food & Feed; Others

2) By Type: Microbiome Drugs; Fecal Microbiota Transplantation (FMT)

3) By Application: Infectious Diseases; Cancers; Gastrointestinal Disorders; Metabolic Diseases; Other Diseases

Companies Mentioned: Assembly Biosciences; Enterome Bioscience; Ferring Pharmaceutical; Vedanta BioSciences; Seres Therapeutics

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; United States

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, micobiome indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Microbiome Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

  • 6.1. Segmentation By Geography
  • 6.2. Segmentation By End Use Industry
  • 6.3. Segmentation By Type
  • 6.4. Segmentation By Application

7. Microbiome Market Characteristics

  • 7.1. Market Definition
  • 7.2. Segmentation By End Use Industry
    • 7.2.1. Human Therapeutics
    • 7.2.2. Human Diagnostics
    • 7.2.3. Agriculture And Environmental
    • 7.2.4. Food And Feed
    • 7.2.5. Others
  • 7.3. Human Microbiome Therapeutics
    • 7.3.1. Fecal Microbiota Transplantation (FMT)
    • 7.3.2. Microbiome Drugs
    • 7.3.3. Infectious Diseases
    • 7.3.4. Gastrointestinal Disorders
    • 7.3.5. Metabolic Disorders
    • 7.3.6. Cancers
    • 7.3.7. Other Diseases

8. COVID-19 Impact On The Microbiome Market

9. Microbiome Market Trends And Strategies

  • 9.1. Strategic Collaborations And Agreements
  • 9.2. Increasing Number Of Pipeline Studies And Drug Development
  • 9.3. Increasing Investments In Development Of Cancer Microbiome Therapeutics
  • 9.4. End-Use Industry Trends
    • 9.4.1. Increasing Research On Microbiomes In Agriculture
    • 9.4.2. Increasing Demand Of Probiotics
    • 9.4.3. Skin Microbiome Products

10. Global Microbiome Market Size And Growth

  • 10.1. Market Size
  • 10.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
    • 10.2.1. Drivers Of The Market 2015 - 2020
    • 10.2.2. Restraints On The Market 2015 - 2020
  • 10.3. Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
    • 10.3.1. Drivers Of The Market 2020 - 2025
    • 10.3.2. Restraints On The Market 2020 - 2025

11. Global Microbiome Market Segmentation

  • 11.1. Global Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 11.1.1. Agriculture & Environmental
    • 11.1.2. Others
    • 11.1.3. Food & Feed
    • 11.1.4. Human Diagnostics
    • 11.1.5. Human Therapeutics
    • 11.1.6. Global Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 11.1.7. Global Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)
    • 11.1.8. Infectious Diseases
    • 11.1.9. Cancers
    • 11.1.10. Gastrointestinal Disorders
    • 11.1.11. Metabolic Disorders

12. Microbiome Market, Regional And Country Analysis

  • 12.1. Global Microbiome Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
  • 12.2. Global Microbiome Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

13. Asia-Pacific Microbiome Market

  • 13.1. Asia-Pacific Microbiome Market Overview
    • 13.1.1. Region Information
    • 13.1.2. Impact of COVID-19
    • 13.1.3. Market Information
    • 13.1.4. Background Information
    • 13.1.5. Government Initiatives
    • 13.1.6. Regulations
    • 13.1.7. Regulatory Bodies
    • 13.1.8. Major Associations
    • 13.1.9. Taxes Levied
    • 13.1.10. Corporate Tax Structure
    • 13.1.11. Investments
    • 13.1.12. Major Companies
  • 13.2. Asia-Pacific Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.3. Asia-Pacific Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 13.4. Asia-Pacific Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 13.4.1. Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 13.4.2. Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)
  • 13.5. Asia-Pacific Microbiome Market: Country Analysis
  • 13.6. China Microbiome Market
  • 13.7. China Microbiome Market Overview
    • 13.7.1. Country Information
    • 13.7.2. Impact of COVID-19
    • 13.7.3. Market Information
    • 13.7.4. Background Information
    • 13.7.5. Government Initiatives
    • 13.7.6. Regulations
    • 13.7.7. Regulatory Bodies
    • 13.7.8. Major Associations
    • 13.7.9. Corporate Tax Structure
    • 13.7.10. Investments
    • 13.7.11. Major Companies
  • 13.8. China Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.9. China Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 13.10. China Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 13.10.1. China Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 13.10.2. China Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)
  • 13.11. India Microbiome Market
  • 13.12. India Microbiome Market Overview
    • 13.12.1. Country Information
    • 13.12.2. Impact of COVID-19
    • 13.12.3. Market Information
    • 13.12.4. Background Information
    • 13.12.5. Government Initiatives
    • 13.12.6. Regulations
    • 13.12.7. Regulatory Bodies
    • 13.12.8. Major Associations
    • 13.12.9. Corporate Tax Structure
    • 13.12.10. Major Companies
  • 13.13. India Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.14. India Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 13.15. India Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 13.15.1. India Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 13.15.2. India Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)
  • 13.16. Japan Microbiome Market
  • 13.17. Japan Microbiome Market Overview
    • 13.17.1. Country Information
    • 13.17.2. Impact of COVID-19
    • 13.17.3. Market Information
    • 13.17.4. Background Information
    • 13.17.5. Government Initiatives
    • 13.17.6. Regulations
    • 13.17.7. Regulatory Bodies
    • 13.17.8. Corporate Tax Structure
    • 13.17.9. Investments
    • 13.17.10. Major Companies
  • 13.18. Japan Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.19. Japan Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 13.20. Japan Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 13.20.1. Japan Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 13.20.2. Japan Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)
  • 13.21. Australia Microbiome Market
  • 13.22. Australia Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.23. Australia Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 13.24. Australia Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 13.24.1. Australia Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 13.24.2. Australia Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)
  • 13.25. Indonesia Microbiome Market
  • 13.26. Indonesia Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.27. Indonesia Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 13.28. Indonesia Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 13.28.1. Indonesia Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 13.28.2. Indonesia Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)
  • 13.29. South Korea Microbiome Market
  • 13.30. South Korea Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 13.31. South Korea Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 13.32. South Korea Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 13.32.1. South Korea Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 13.32.2. South Korea Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)

14. Western Europe Microbiome Market

  • 14.1. Western Europe Microbiome Market Overview
    • 14.1.1. Region Information
    • 14.1.2. Impact Of COVID-19
    • 14.1.3. Market Information
    • 14.1.4. Background Information
    • 14.1.5. Government initiatives
    • 14.1.6. Regulations
    • 14.1.7. Regulatory Bodies
    • 14.1.8. Major Associations
    • 14.1.9. Taxes Levied
    • 14.1.10. Corporate Tax Structure
    • 14.1.11. Investments
    • 14.1.12. Major Companies
  • 14.2. Western Europe Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 14.3. Western Europe Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 14.4. Western Europe Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 14.4.1. Western Europe Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 14.4.2. Western Europe Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)
  • 14.5. Western Europe Microbiome Market: Country Analysis
  • 14.6. UK Microbiome Market
  • 14.7. UK Microbiome Market Overview
    • 14.7.1. Country Information
    • 14.7.2. Impact Of COVID-19
    • 14.7.3. Market Information
    • 14.7.4. Background Information
    • 14.7.5. Government Initiatives
    • 14.7.6. Regulations
    • 14.7.7. Regulatory Bodies
    • 14.7.8. Major Associations
    • 14.7.9. Taxes Levied
    • 14.7.10. Corporate Tax Structure
    • 14.7.11. Investments
    • 14.7.12. Major Companies
  • 14.8. UK Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 14.9. UK Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 14.10. UK Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 14.10.1. UK Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 14.10.2. UK Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)
  • 14.11. Germany Microbiome Market
  • 14.12. Germany Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 14.13. Germany Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 14.14. Germany Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 14.14.1. Germany Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 14.14.2. Germany Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)
  • 14.15. France Microbiome Market
  • 14.16. France Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 14.17. France Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 14.18. France Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 14.18.1. France Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 14.18.2. France Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)

15. Eastern Europe Microbiome Market

  • 15.1. Eastern Europe Microbiome Market Overview
    • 15.1.1. Region Information
    • 15.1.2. Impact Of COVID-19
    • 15.1.3. Market Information
    • 15.1.4. Background Information
    • 15.1.5. Regulations
    • 15.1.6. Regulatory Bodies
    • 15.1.7. Major Associations
    • 15.1.8. Taxes Levied
    • 15.1.9. Corporate Tax Structure
    • 15.1.10. Investments
    • 15.1.11. Major Companies
  • 15.2. Eastern Europe Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 15.3. Eastern Europe Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 15.4. Eastern Europe Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 15.4.1. Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 15.4.2. Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)
  • 15.5. Eastern Europe Microbiome Market: Country Analysis
  • 15.6. Russia Microbiome Market
  • 15.7. Russia Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 15.8. Russia Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 15.9. Russia Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 15.9.1. Russia Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 15.9.2. Russia Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)

16. North America Microbiome Market

  • 16.1. North America Microbiome Market Overview
    • 16.1.1. Region Information
    • 16.1.2. Impact Of COVID-19
    • 16.1.3. Market Information
    • 16.1.4. Background Information
    • 16.1.5. Government Initiatives
    • 16.1.6. Regulations
    • 16.1.7. Regulatory Bodies
    • 16.1.8. Major Associations
    • 16.1.9. Taxes Levied
    • 16.1.10. Corporate Tax Structure
    • 16.1.11. Investments
    • 16.1.12. Major Companies
  • 16.2. North America Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 16.3. North America Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 16.4. North America Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 16.4.1. North America Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 16.4.2. North America Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)
  • 16.5. North America Microbiome Market: Country Analysis
  • 16.6. USA Microbiome Market
  • 16.7. USA Microbiome Market Overview
    • 16.7.1. Country Information
    • 16.7.2. Impact Of COVID-19
    • 16.7.3. Market Information
    • 16.7.4. Background Information
    • 16.7.5. Government Initiatives
    • 16.7.6. Regulations
    • 16.7.7. Regulatory Bodies
    • 16.7.8. Major Associations
    • 16.7.9. Corporate Tax Structure
    • 16.7.10. Investments
    • 16.7.11. Major Companies
  • 16.8. USA Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 16.9. USA Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 16.10. USA Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 16.10.1. USA Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 16.10.2. USA Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)

17. South America Microbiome Market

  • 17.1. South America Microbiome Market Overview
    • 17.1.1. Region Information
    • 17.1.2. Market Information
    • 17.1.3. Impact Of COVID-19
    • 17.1.4. Background Information
    • 17.1.5. Government Initiatives
    • 17.1.6. Regulations
    • 17.1.7. Regulatory Bodies
    • 17.1.8. Major Associations
    • 17.1.9. Taxes Levied
    • 17.1.10. Corporate Tax Structure
    • 17.1.11. Investments
    • 17.1.12. Major Companies
  • 17.2. South America Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.3. South America Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 17.4. South America Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 17.4.1. South America Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 17.4.2. South America Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)
  • 17.5. South America Microbiome Market: Country Analysis
  • 17.6. Brazil Microbiome Market
  • 17.7. Brazil Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 17.8. Brazil Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 17.9. Brazil Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 17.9.1. Brazil Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 17.9.2. Brazil Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)

18. Middle East Microbiome Market

  • 18.1. Middle East Microbiome Market Overview
    • 18.1.1. Region Information
    • 18.1.2. Market Information
    • 18.1.3. Impact Of COVID-19
    • 18.1.4. Background Information
    • 18.1.5. Government Initiatives
    • 18.1.6. Regulations
    • 18.1.7. Regulatory Bodies
    • 18.1.8. Major Associations
    • 18.1.9. Taxes Levied
    • 18.1.10. Corporate Tax Structure
    • 18.1.11. Investments
    • 18.1.12. Major Companies
  • 18.2. Middle East Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 18.3. Middle East Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 18.4. Middle East Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 18.4.1. Middle East Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 18.4.2. Middle East Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)

19. Africa Microbiome Market

  • 19.1. Africa Microbiome Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Market Information
    • 19.1.3. Impact Of COVID-19
    • 19.1.4. Background Information
    • 19.1.5. Government Initiatives
    • 19.1.6. Regulations
    • 19.1.7. Regulatory Bodies
    • 19.1.8. Major Associations
    • 19.1.9. Taxes Levied
    • 19.1.10. Corporate Tax Structure
    • 19.1.11. Investments
    • 19.1.12. Major Companies
  • 19.2. Africa Microbiome Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
  • 19.3. Africa Microbiome Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
  • 19.4. Africa Microbiome Market, Segmentation By End Use Industry, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
    • 19.4.1. Africa Human Microbiome Therapeutics Market, Segmentation By Type, Forecast, 2023 - 2030, Value ($ Million)
    • 19.4.2. Africa Human Microbiome Therapeutics Market, Segmentation By Application, Forecast, 2023 - 2030, Value ($ Million)

20. Global Microbiome Market Competitive Landscape

  • 20.1. Company Profiles
  • 20.2. Assembly Biosciences
    • 20.2.1. Company Overview
    • 20.2.2. Products And Services
    • 20.2.3. Business Strategy
    • 20.2.4. Financial Overview
  • 20.3. Enterome Bioscience
    • 20.3.1. Company Overview
    • 20.3.2. Products And Services
    • 20.3.3. Business Strategy
    • 20.3.4. Financial Overview
  • 20.4. Ferring Pharmaceuticals
    • 20.4.1. Company Overview
    • 20.4.2. Products And Services
    • 20.4.3. Financial Overview
  • 20.5. Vedanta BioSciences
    • 20.5.1. Company Overview
    • 20.5.2. Products And Services
    • 20.5.3. Business Strategy
    • 20.5.4. Financial Overview
  • 20.6. Seres Therapeutics
    • 20.6.1. Company Overview
    • 20.6.2. Products And Services
    • 20.6.3. Business Strategy
    • 20.6.4. Financial Overview
  • 20.7. Second Genome Inc.
    • 20.7.1. Company Overview
    • 20.7.2. Products And Services
    • 20.7.3. Business Strategy
    • 20.7.4. Financial Overview

21. Key Mergers And Acquisitions In The Microbiome Market

  • 21.1. Novozymes Acquired Biota
  • 21.2. Lallemand Inc Acquired Biotec BetaGlucans AS
  • 21.3. Novozymes Acquired Microbiome Labs
  • 21.4. Royal DSM Acquired Erber Group
  • 21.5. Chr Hansen Holding A/S Acquired Jennewein Biotechnologie GmbH
  • 21.6. Chr Hansen Holding A/S Acquired UAS Laboratories LLC
  • 21.7. CanBiocin Inc Acquired Pure Cultures Inc.
  • 21.8. Royal DSM Acquired Glycom A/S
  • 21.9. Phibro Animal Health Acquired Osprey Biotechnics, Inc.

22. Microbiome Market Opportunities & Strategies

  • 22.1. Global Microbiome Market In 2025 - Countries Offering Most New Opportunities
  • 22.2. Global Microbiome Market In 2025 - Segments Offering Most New Opportunities
  • 22.3. Global Microbiome Market In 2025 - Growth Strategies
    • 22.3.1. Market Trend Based Strategies
    • 22.3.2. Competitor Strategies

23. Microbiome Market, Conclusions And Recommendations

  • 23.1. Conclusions
  • 23.2. Recommendations
    • 23.2.1. Product
    • 23.2.2. Place
    • 23.2.3. Price
    • 23.2.4. Promotion
    • 23.2.5. People

24. Appendix

  • 24.1. Market Data Sources
  • 24.2. Research Methodology
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company
  • 24.6. Copyright and Disclaimer